# Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

> **NCT00971399** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 172 (estimated)

## Conditions studied

- Radiotherapy Induced Nausea and Vomiting

## Interventions

- **DRUG:** ramosetron
- **DRUG:** ondansetron

## Key facts

- **NCT ID:** NCT00971399
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-02
- **Final completion:** —
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2011-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971399, "Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00971399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*